我只关心，怎么股票又_老虎社区_美港股上老虎 - 老虎社区

点赞
1
收藏

villy
2021-12-08

我只关心，怎么股票又跌了。。。

辉瑞-BioNTech：三剂新冠疫苗可中和奥密克戎变异株

12月8日讯，辉瑞-BioNTech实验室测试显示，接种第三剂新冠疫苗可以中和奥密克戎变异株，接种两剂疫苗对其的中和效果明显较差，两剂疫苗仍可预防严重疾病。辉瑞-BioNTech将继续研发一种针对奥

辉瑞-BioNTech：三剂新冠疫苗可中和奥密克戎变异株

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

点赞

举报

评论（1）

推荐
最新

Fred_6810
·2021-12-09
加仓呗
回复
点赞
举报

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":602353870,"tweetId":"602353870","gmtCreate":1638975157096,"gmtModify":1638975157096,"author":{"id":3577951726287032,"idStr":"3577951726287032","authorId":3577951726287032,"authorIdStr":"3577951726287032","name":"villy","avatar":"https://static.tigerbbs.com/a904e58e7c8c453f3d60f533c6f3cbbb","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>我只关心，怎么股票又跌了。。。</p></body></html>","htmlText":"<html><head></head><body><p>我只关心，怎么股票又跌了。。。</p></body></html>","text":"我只关心，怎么股票又跌了。。。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/602353870","repostId":1124189543,"repostType":2,"repost":{"id":"1124189543","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638964689,"share":"https://www.laohu8.com/m/news/1124189543?lang=&edition=full","pubTime":"2021-12-08 19:58","market":"other","language":"zh","title":"辉瑞-BioNTech：三剂新冠疫苗可中和奥密克戎变异株","url":"https://stock-news.laohu8.com/highlight/detail?id=1124189543","media":"老虎资讯综合","summary":"12月8日讯，辉瑞-BioNTech实验室测试显示，接种第三剂新冠疫苗可以中和奥密克戎变异株，接种两剂疫苗对其的中和效果明显较差，两剂疫苗仍可预防严重疾病。\n辉瑞-BioNTech将继续研发一种针对奥","content":"<p>12月8日讯，辉瑞-BioNTech实验室测试显示，接种第三剂新冠疫苗可以中和奥密克戎变异株，接种两剂疫苗对其的中和效果明显较差，两剂疫苗仍可预防严重疾病。</p>\n<p>辉瑞-BioNTech将继续研发一种针对奥密克戎变异株的疫苗，并预计在明年3月之前推出，以备需要进行适应。</p>\n<p><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>称，第三剂疫苗针对奥密克戎变异株的BNT162B2中和抗体滴度比两剂疫苗的滴度增加25倍。</p>\n<p>辉瑞CEO称，虽然两剂疫苗可能仍然可以对奥密克戎变异株引起的重症提供保护，但从这些初步数据可以清楚地看出，接种第三剂疫苗可以改善保护效果。</p>\n<p>截至发稿，<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>、<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>跌幅分别收窄至0.14%和2.63%。</p>\n<p><img src=\"https://static.tigerbbs.com/ca3721446cb779b422f60fb225566462\" tg-width=\"867\" tg-height=\"652\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>辉瑞-BioNTech：三剂新冠疫苗可中和奥密克戎变异株 </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n辉瑞-BioNTech：三剂新冠疫苗可中和奥密克戎变异株 \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-08 19:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>12月8日讯，辉瑞-BioNTech实验室测试显示，接种第三剂新冠疫苗可以中和奥密克戎变异株，接种两剂疫苗对其的中和效果明显较差，两剂疫苗仍可预防严重疾病。</p>\n<p>辉瑞-BioNTech将继续研发一种针对奥密克戎变异株的疫苗，并预计在明年3月之前推出，以备需要进行适应。</p>\n<p><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>称，第三剂疫苗针对奥密克戎变异株的BNT162B2中和抗体滴度比两剂疫苗的滴度增加25倍。</p>\n<p>辉瑞CEO称，虽然两剂疫苗可能仍然可以对奥密克戎变异株引起的重症提供保护，但从这些初步数据可以清楚地看出，接种第三剂疫苗可以改善保护效果。</p>\n<p>截至发稿，<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>、<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>跌幅分别收窄至0.14%和2.63%。</p>\n<p><img src=\"https://static.tigerbbs.com/ca3721446cb779b422f60fb225566462\" tg-width=\"867\" tg-height=\"652\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124189543","content_text":"12月8日讯，辉瑞-BioNTech实验室测试显示，接种第三剂新冠疫苗可以中和奥密克戎变异株，接种两剂疫苗对其的中和效果明显较差，两剂疫苗仍可预防严重疾病。\n辉瑞-BioNTech将继续研发一种针对奥密克戎变异株的疫苗，并预计在明年3月之前推出，以备需要进行适应。\n辉瑞称，第三剂疫苗针对奥密克戎变异株的BNT162B2中和抗体滴度比两剂疫苗的滴度增加25倍。\n辉瑞CEO称，虽然两剂疫苗可能仍然可以对奥密克戎变异株引起的重症提供保护，但从这些初步数据可以清楚地看出，接种第三剂疫苗可以改善保护效果。\n截至发稿，辉瑞、BioNTech SE跌幅分别收窄至0.14%和2.63%。","news_type":1,"symbols_score_info":{"BNTX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2439,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":26,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":6901961,"commentId":"6901961","gmtCreate":1638979222657,"gmtModify":1638979378690,"authorId":3563140991934227,"author":{"id":3563140991934227,"idStr":"3563140991934227","authorId":3563140991934227,"name":"Fred_6810","avatar":"https://static.tigerbbs.com/fbe236f23155302a4dcecbf04d2e9040","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":602353870,"objectIdStr":"602353870","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"加仓呗","text":"加仓呗","html":"加仓呗","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}